Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Erdelmeier
Clemens Erdelmeier, Karlsruhe DE
| Patent application number | Description | Published |
|---|---|---|
| 20080286391 | Method for preparing ginkgo extracts having a low content of 4'-O-methyl pyridoxine and/or biflavones - The present invention relates to an improved multi-step method for preparing an extract from ginkgo biloba having a reduced content of 4′-O-methyl pyridoxine and/or biflavones, wherein the depletion is carried out by filtration over an adsorber resin and/or an ion exchanger and the substances to be removed are retained on the resin. The invention further relates to an extract from ginkgo biloba having a reduced content of 4′-O-methyl pyridoxine and/or biflavones, which is obtainable by the method according to the present invention, as well as to its use. | 11-20-2008 |
Irene Erdelmeier, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100010049 | Novel Tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof - Compounds corresponding to the following general formula (I): | 01-14-2010 |
| 20100055291 | PROCESS FOR PREPARING 2-HYDROXY-4-METHYLSELENOBUTYRIC ACID, ALONE OR AS A MIXTURE WITH ITS SULPHUR-CONTAINING ANALOGUE, AND USES THEREOF IN NUTRITION, IN PARTICULAR ANIMAL NUTRITION - The present invention relates to a novel process for preparing 2-hydroxy-4-methylselenobutyric acid from 3-methylselenoproprion-aldehyde. The 2-hydroxy-4-methylselenobutyric acid is obtained alone or as a mixture with its sulphur-containing analogue. The invention also relates to the compositions, in particular nutritional compositions, comprising a mixture of 2-hydroxy-4-methylselenobutyric acid and 2-hydroxy-4-methylthiobutyric acid, and a physiologically acceptable medium, and to the use of this mixture as a dietary ingredient. | 03-04-2010 |
Irène Erdelmeier, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100010049 | Novel Tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof - Compounds corresponding to the following general formula (I): | 01-14-2010 |
Martin Erdelmeier, Schifferstadt DE
| Patent application number | Description | Published |
|---|---|---|
| 20090327106 | MANAGING CONSISTENT INTERFACES FOR FINANCIAL INSTRUMENT BUSINESS OBJECTS ACROSS HETEROGENEOUS SYSTEMS - A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction. In some operations, software creates, updates, or otherwise processes information related to a financial instrument position accounting period total analytical result, a financial instrument position accounting valuation analytical result, a financial instrument position accrual analytical result, a financial instrument position fair value analytical result, and/or a financial instrument position period average volume analytical result business object. | 12-31-2009 |